Gilead Sciences, Inc.(NASDAQ : GILD)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-2.32%||6.32||0.7%||$441.79m|
|GILD||Gilead Sciences, Inc.||-2.37%||66.03||1.0%||$416.36m|
|REGN||Regeneron Pharmaceuticals, Inc.||-2.09%||541.68||2.7%||$400.45m|
|XLRN||Acceleron Pharma, Inc.||0.08%||173.08||5.3%||$345.73m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.40%||181.05||1.9%||$258.56m|
|XENE||Xenon Pharmaceuticals, Inc.||-8.17%||30.91||0.4%||$163.63m|
|CRSP||CRISPR Therapeutics AG||-0.97%||96.06||0.6%||$151.40m|
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.